Hubei Biocause Heilen Pharmaceutical Co. Ltd. Financial Flexibility Index
Hubei Biocause Heilen Pharmaceutical Co. Ltd. financial flexibility index. Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211) has a Financial Flexibility Index of 0.20x as of September 2025. Free cash flow of CN¥28.21 Million (operating CF CN¥11.57 Million minus capex CN¥16.64 Million) represents 0% of total liabilities (CN¥142.19 Million). See Hubei Biocause Heilen Pharmaceutical Co. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Hubei Biocause Heilen Pharmaceutical Co. Ltd. (2017–2025)
Financial flexibility index of Hubei Biocause Heilen Pharmaceutical Co. Ltd. from 2017 to 2025. Historical Financial Flexibility Index trend for Hubei Biocause Heilen Pharmaceutical Co. Ltd. across 9 annual periods. Check earnings quality score of Hubei Biocause Heilen Pharmaceutical Co. to evaluate the quality of earnings relative to operating cash generation.
Hubei Biocause Heilen Pharmaceutical Co. Ltd. Financial Flexibility Index by Year (2017–2025)
Hubei Biocause Heilen Pharmaceutical Co. Ltd. financial flexibility index by year from 2017 to 2025. Year-by-year free cash flow to debt coverage for Hubei Biocause Heilen Pharmaceutical Co. Ltd.. For the full cash flow conversion analysis, see 301211 cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.47x | CN¥59.88 Million | CN¥7.55 Million | CN¥128.65 Million | ▼ -68.0% |
| 2024 | 1.46x | CN¥260.50 Million | CN¥96.07 Million | CN¥178.97 Million | ▼ -14.6% |
| 2023 | 1.70x | CN¥323.60 Million | CN¥137.06 Million | CN¥189.89 Million | ▲ +15.4% |
| 2022 | 1.48x | CN¥326.75 Million | CN¥250.79 Million | CN¥221.22 Million | ▲ +9.5% |
| 2021 | 1.35x | CN¥145.05 Million | CN¥123.98 Million | CN¥107.53 Million | ▲ +2.7% |
| 2020 | 1.31x | CN¥135.06 Million | CN¥121.67 Million | CN¥102.85 Million | ▼ -16.5% |
| 2019 | 1.57x | CN¥404.67 Million | CN¥372.33 Million | CN¥257.31 Million | ▲ +273.3% |
| 2018 | 0.42x | CN¥101.26 Million | CN¥76.18 Million | CN¥240.36 Million | ▲ +283.0% |
| 2017 | -0.23x | CN¥-52.32 Million | CN¥-65.44 Million | CN¥227.25 Million | — |